Richard W. Compans
Impact in
- Virology top 0.1%
- HIV Research and Treatment
- Pharmaceutical Science top 0.02%
- Advancements in Transdermal Drug Delivery
Papers in
- Virology 99
- HIV Research and Treatment 90
- Epidemiology 275
- Influenza Virus Research Studies 152
- Respiratory viral infections research 100
- Virology and Viral Diseases 77
- Co-authors
- Sang‐Moo KangPurnell W. ChoppinFu‐Shi QuanMark R. PrausnitzIoanna SkountzouPeter PaleseBao‐Zhong WangLawrence A. Caliguiri
- Journals
- Journal of Virology (106 papers)Virology (94 papers)PLoS ONE (18 papers)Vaccine (13 papers)Proceedings of the National Academy of Sciences (13 papers)
- Partner nations
- United StatesSouth KoreaChina
In The Last Decade
Richard W. Compans
469 papers receiving 25.4k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Virology 3.1k
- Pharmaceutical Science 3.3k
- Infectious Diseases 7.1k
- Immunology 7.8k
- Epidemiology 12.0k
Countries citing papers authored by Richard W. Compans
This map shows the geographic impact of Richard W. Compans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard W. Compans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard W. Compans more than expected).
Fields of papers citing papers by Richard W. Compans
This network shows the impact of papers produced by Richard W. Compans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard W. Compans. The network helps show where Richard W. Compans may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard W. Compans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2021 | 57 | |
| 3 | 2020 | 5 | |
| 4 | 2019 | 27 | |
| 5 | 2018 | 202 | |
| 6 | 2018 | 43 | |
| 7 | 2017 | 80 | |
| 8 | 2016 | 50 | |
| 9 | 2015 | 73 | |
| 10 | 2015 | 34 | |
| 11 | 2014 | 13 | |
| 12 | 2010 | 129 | |
| 13 | 2009 | 170 | |
| 14 | 1994 | 12 | |
| 15 | 1992 | 2 | |
| 16 | 1990 | 41 | |
| 17 | 1990 | 22 | |
| 18 | Segmented negative strand viruses : arenaviruses, bunyaviruses, and orthomyxoviruses | 1984 | 9 |
| 19 | Nonsegmented negative strand viruses : paramyxoviruses and rhabdoviruses | 1984 | 7 |
| 20 | 1980 | 15 |
About Richard W. Compans
Richard W. Compans is a scholar working on Virology, Epidemiology, Pharmaceutical Science, Immunology and Infectious Diseases, having authored 469 papers that have together received 26.7k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (152 papers), Respiratory viral infections research (100 papers), HIV Research and Treatment (90 papers), Virology and Viral Diseases (77 papers), Virus-based gene therapy research (71 papers), Immunotherapy and Immune Responses (61 papers), Bacteriophages and microbial interactions (49 papers) and Viral Infections and Vectors (47 papers). The work is most often cited by research in Virology (3.1k citations), Pharmaceutical Science (3.3k citations), Infectious Diseases (7.1k citations), Immunology (7.8k citations) and Epidemiology (12.0k citations). Richard W. Compans has collaborated with scholars based in United States, South Korea and China. Frequent co-authors include Sang‐Moo Kang, Purnell W. Choppin, Fu‐Shi Quan, Mark R. Prausnitz, Ioanna Skountzou, Peter Palese, Bao‐Zhong Wang, Lawrence A. Caliguiri, R V Srinivas and Jae-Min Song. Their work appears in journals such as Journal of Virology, Virology, PLoS ONE, Vaccine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.